Education
About Us
Working with TipRanks
Follow Us
Lexington Biosciences (LXGTF)
:LXGTF
LXGTF Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume1.51K
Average Volume (3M)113.00
Market Cap
$222.98K
Enterprise Value$903.36K
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta13.40
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,786,840
10 Day Avg. Volume80
30 Day Avg. Volume113
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.07
Price to Sales (P/S)0.00
P/FCF Ratio-0.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LXGTF FAQ
What was Lexington Biosciences ’s price range in the past 12 months?
Currently, no data Available
What is Lexington Biosciences ’s market cap?
Lexington Biosciences ’s market cap is $222.98K.
When is Lexington Biosciences ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lexington Biosciences ’s earnings last quarter?
Currently, no data Available
Is Lexington Biosciences overvalued?
According to Wall Street analysts Lexington Biosciences ’s price is currently Overvalued.
Does Lexington Biosciences pay dividends?
Lexington Biosciences does not currently pay dividends.
What is Lexington Biosciences ’s EPS estimate?
Lexington Biosciences ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lexington Biosciences have?
Lexington Biosciences has 3,786,840 shares outstanding.
What happened to Lexington Biosciences ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lexington Biosciences ?
Currently, no hedge funds are holding shares in LXGTF
Company Description
Lexington Biosciences
Registered Plan Private Investments Inc. operates as a private investment platform company. Its platform would allow investors to use their registered plans at their own direction to invest in private companies. The company was formerly known as Lexington Biosciences, Inc. and changed its name to Registered Plan Private Investments Inc. in May 2020. The company was incorporated in 2016 and is headquartered in Vancouver, Canada.
Lexinfintech Holdings
―
Aethlon Medical
―
Clearside Biomedical
―
Biogen
―
Gilead Sciences
―
Incyte
―